Bailey Dove/Victrelis

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 5: Line 5:
<StructureSection load='1stp' size='340' side='right' caption='Caption for this structure' scene=''>
<StructureSection load='1stp' size='340' side='right' caption='Caption for this structure' scene=''>
-
This is a default text for your page '''Bailey Dove/Victrelis'''. Click above on '''edit this page''' to modify. Be careful with the &lt; and &gt; signs.
 
-
You may include any references to papers as in: the use of JSmol in Proteopedia <ref>DOI 10.1002/ijch.201300024</ref> or to the article describing Jmol <ref>PMID:21638687</ref> to the rescue.
 
== Function ==
== Function ==

Revision as of 21:36, 10 November 2016

Victrelis

Victrelis (boceprevir) is an antiviral Hepatitis C medication approved by the United States Food and Drug Administration in 2011. Victrelis is an inhibitor of the non-structural protein 3 (NS3) serine protease. The medication inhibits viral replication in Hepatitis C virus infected cells. [1]


Caption for this structure

Drag the structure with the mouse to rotate

References

  1. Merck & Co., Inc. (n.d.) Highlights of prescribing information. Retrieved from https://www.merck.com/product/usa/pi_circulars/v/victrelis/victrelis_pi.pdf
  2. Pawlotsky JM. Pathophysiology of hepatitis C virus infection and related liver disease. Trends Microbiol. 2004 Feb;12(2):96-102. PMID:15036326 doi:http://dx.doi.org/10.1016/j.tim.2003.12.005
  3. Centers for Disease Control and Prevention. (2015). Viral Hepatitis - Hepatitis C Information. Retrieved from http://www.cdc.gov/hepatitis/hcv/index.htm
  4. Zhu Y, Chen S. Antiviral treatment of hepatitis C virus infection and factors affecting efficacy. World J Gastroenterol. 2013 Dec 21;19(47):8963-73. doi: 10.3748/wjg.v19.i47.8963. PMID:24379621 doi:http://dx.doi.org/10.3748/wjg.v19.i47.8963
  5. Robalino J, Browdy CL, Prior S, Metz A, Parnell P, Gross P, Warr G. Induction of antiviral immunity by double-stranded RNA in a marine invertebrate. J Virol. 2004 Oct;78(19):10442-8. PMID:15367610 doi:http://dx.doi.org/10.1128/JVI.78.19.10442-10448.2004

[1] [2] [3] [4] [5]

Proteopedia Page Contributors and Editors (what is this?)

Bailey Dove, Michal Harel

Personal tools